Breastfeeding Zantac Infants
| Zantac is the brand name of the drug called Ranitidine Hydrochloride. Ranitidine belongs to a group of drugs called histamine-2 blockers. Zantac is a reversible inhibitor of histamine-H2 receptors and is prescribed to reduce acidity in the stomach. Other medical conditions where Zantac is prescribed include treatment of ulcers in the stomach and intestine, conditions like Zollinger-Ellison syndrome where stomach produces excess acid, gastro-esophageal reflux disease (GERD), erosive esophagitis and heartburns when acid backs up into the esophagus from stomach. Zantac prevents recurrence of gastric or duodenal ulcers. |
Zantac is an effervescent tablet available in two dosage forms including Zantac 75 and Zantac 150. Hence, these tablets should be dissolved in water before taking. Patients suffering from Phenylketonuria should inform the doctor before taking Zantac since all effervescent tablets contain phenylalanine. Some of the symptoms associated with Zantac intake include headache and vomiting. One should have a prior consultation with the doctor before taking Zantac if the patient is having kidney problem, liver disease, porphyria or is allergic to the drug. Zantac increases the risk of developing pneumonia in patients.
Zantac is a pregnancy category B drug expected not to cause any harm to new born babies. However, Zantac does pass through breast milk. According to data from American Association of Pediatrics, it gets concentrated in breast milk at up to seven times the plasma levels. However, there are no reports indicating that Zantac is carcinogenic or teratogenic or even mutagenic. Research has shown that Ranitidine does not have any antiandrogenic activity. However, it is advisable that breast feeding women consult their physicians before taking Zantac.
More Articles :
|
